https://www.statcounter.com/counter/counter.js
Web Analytics
Home » 2019 » June
Guselkumab meets primary endpoints in phase 3 psoriatic arthritis program

Guselkumab meets primary endpoints in phase 3 psoriatic arthritis program

Johnson & Johnson’s Janssen Pharmaceutical said that its IL-23 p19 inhibitor TREMFYA (guselkumab) met the primary endpoints of American College of Rheumatology 20% improvement (ACR20) in two phase 3 trials in adults with active psoriatic arthritis. Safety profiles observed for guselkumab in the two trials – DISCOVER 1 and 2 were in line with its […]

ZULRESSO postpartum depression drug set to be launched in US by Sage Therapeutics

CNS biopharma company Sage Therapeutics is all set to commercially launch its ZULRESSO (brexanolone) injection in the US later this month for the treatment of postpartum depression (PPD), a major depressive episode that can occur during pregnancy or after delivery. Sage Therapeutics said that the US Drug Enforcement Administration (DEA) has put ZULRESSO into Schedule […]

Continue reading …
US neurobehavioral health company BlackThorn raises $76m to advance AI-driven targeted therapeutics

California-based neurobehavioral health company BlackThorn Therapeutics has raised $76 million through a Series B financing round to advance targeted therapeutics using the next-generation artificial intelligence (AI) technologies. The new investors in BlackThorn Therapeutics are Polaris Partners, Premier Partners, Vertex Ventures HC, and Scripps Research. Existing investors Alexandria Venture Investments, Johnson & Johnson Innovation, Altitude Life […]

Continue reading …
Pixuvri EMA approval : Servier NHL drug secures standard marketing authorization in Europe

Pixuvri EMA approval : French pharma company Servier has secured full approval for Pixuvri (pixantrone) from the European Commission (EC) as monotherapy for aggressive non-Hodgkin B-cell lymphoma (NHL) in adult patients whose condition is multiply relapsed or refractory. Pixuvri EMA approval Since 2012, Pixantrone has been available in Europe to patients following conditional approval, which […]

Continue reading …
OSSIO launches OSSIOfiber Bone Pin for hammertoe correction in US

Israeli orthopedic medical device company OSSIO has launched the OSSIOfiber Bone Pin Family for maintenance of alignment and fixation of bone fractures, arthrodesis, bone grafts, and osteotomies. The first commercial cases of the the OSSIOfiber Bone Pin Family was in the hammertoe repairs carried out at Polaris Surgery Center in Westerville, Ohio. Dr Gregory Berlet, […]

Continue reading …
Boston Scientific to acquire spinal medical devices manufacturer Vertiflex

Boston Scientific acquisition of Vertiflex : US medical devices manufacturer Boston Scientific has agreed to acquire Vertiflex, a California-based manufacturer of spinal medical devices, for $465 million. Vertiflex has a minimally-invasive device called Superion Indirect Decompression System, which has been designed to enhance physical function and reduce pain in patients with lumbar spinal stenosis (LSS). […]

Continue reading …
Pfizer opens $200m biologics clinical manufacturing facility in Andover, MA

US pharma giant Pfizer has opened Andover Clinical Manufacturing Facility (ACMF), a new 175,000sft biologics clinical manufacturing facility built with an investment of over $200 million in Andover, Massachusetts. The biologics clinical manufacturing facility will be used for the development and production of complex biologics and vaccines and is expected to expand Pfizer’s BioTherapeutics Pharmaceutical […]

Continue reading …
Imricor to install MRI ablation Center in Haga Hospital in The Hague

Imricor Medical Systems has bagged a contract to install an MRI ablation center for the treatment of cardiac arrhythmias at the Haga Hospital in The Hague, Netherlands. The advanced MRI ablation center will feature a 1.5T MRI scanner along with Imricor’s Advantage-MR EP Recorder/Stimulator System. Dr. Vincent van Driel – Director of Electrophysiology at the […]

Continue reading …
SHINE breaks ground on medical isotope production facility in Janesville, WI

SHINE Medical Technologies, a US radioisotopes manufacturer, began construction on its first medical isotope production facility in Janesville in Wisconsin. The groundbreaking ceremony on the medical isotope production facility follows the allocation of 91 acres of land by the City of Janesville to SHINE Medical Technologies to develop the project, which is located across from […]

Continue reading …